About
Products
Global Health
VISITECT CD4 Advanced Disease
VISITECT CD4
Food Intolerance
Allergy
News & Events
Quality
Investor Relations
Directors
Colin King, MBA
Kieron Harbinson, FCCA
Jag Grewal, BSc Hons, MSC, MBA
William Rhodes, BS, MSIB
Jeremy Millard
Corporate Information
Share Holder Information
Advisors
RNS Announcements
Corporate Governance
Contact
:
Investor Relations
RNS Announcements
Investor Relations
Directors
Colin King, MBA
Kieron Harbinson, FCCA
Jag Grewal, BSc Hons, MSC, MBA
William Rhodes, BS, MSIB
Jeremy Millard
Corporate Information
Share Holder Information
Advisors
RNS Announcements
Corporate Governance
To sign up to receive Investor News as it is released please email
Walbrook PR
22/05/19
Subscription to raise c.£635,000
17/04/19
Trading Update
18/03/19
CD4 Advanced Disease CE-Mark
06/03/19
VISITECT CD4 Update
01/03/19
Board Appointment
29/01/19
VISITECT CD4 Advanced Disease Validation
10/12/18
Directorate Change
03/12/18
Interim Results - Six months ended 30 Sep 2018
19/10/18
Holding(s) in Company
10/10/18
Trading Update
27/09/18
Allersys CE Mark
14/09/18
Result of AGM
10/09/18
Holding(s) in Company
06/06/18
FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2018
06/08/18
VISITECT® CD4 Advanced Disease Development Update
18/07/18
VISITECT® CD4 commercialisation update
02/07/18
Notice of Results - RNS
28/06/18
Disposal of Infectious Disease Business
21/05/18
VISITECT CD4 Update
08/05/18
Allersys CE Mark
02/05/18
Closure of Omega Diagnostics GmbH
24/04/18
PDRM Dealing
24/04/18
Holding(s) in Company
23/04/18
Holding(s) in Company
23/04/18
Director/PDMR Shareholding
23/04/18
Holding(s) in Company
23/04/18
Director/PDMR Shareholding
20/04/18
Allersys Distributon Agreement
10/04/18
Strategic Review of Operations and Trading Update
10/04/18
Price Monitoring Extension
12/01/18
Holding(s) in Company
21/12/17
Allersys® CE-Mark
14/12/17
CEO Succession
29/11/17
VISITECT
®
CD4 CE-Mark
01/11/17
Change of Registered Address
23/10/17
T
rading Update and Notice of Interim Results
16/10/17
US Supply Agreement
10/10/17
Holding(s) in Company
05/09/17
Exercise of Options and Total Voting Rights
29/08/17
Result of AGM
18/07/17
Result of General Meeting
17/07/17
Result of Open Offer
06/07/17
Sale and leaseback of the building owned by Omega GmbH
30/06/17
Result of Proposed Fundraising
30/06/17
Proposed Fundraising
30/06/17
Final Results - FY17
25/04/17
Trading Update and Notice of Results
21/04/17
Holding(s) in Company
29/03/17
VISITECT® Malaria CE-Mark and successful Indian FDA inspection
07/03/17
Holding(s) in Company
27/02/17
Holding(s) in Company
22/01/17
Update on discussions with Immunodiagnostic Systems Holdings plc
11/01/17
ISO accreditation for manufacturing facility in Pune, India
24/11/16
Holding(s) in Company
17/10/16
Trading Update and Notice of Interim Results
10/08/16
Result of AGM
02/08/16
R&D Grant Funding
04/07/16
Holding(s) in Company
01/07/16
Holding(s) in Company
27/06/16
Final Results - FY16
09/06/16
Holding(s) in Company
21/04/16
Trading Update and Notice of Results
08/02/16
Holding(s) in Company